KANNAWAY SUCCESS STORIES

​
​FOR RESEARCH ON ANY CONDITION AND CBD VISIT www.echoconnection.org 

CBD AND CANCER
California-based naturopathic oncologist Moses Goldberg, ND recently advocated cannabidiol (CBD) as a beneficial form of treatment for patients diagnosed with breast cancer. In an op-ed published in Bohemian.com, an online lifestyle magazine focused on Sonoma, Marin and Napa counties, Dr. Goldberg described the cannabinoid "CBD" as a potential “ally in an integrative approach to cancer and coping with and combating the side effects of conventional cancer-fighting therapies.”

CBD AND DEMENTIA
The word dementia describes a class of heterogeneous diseases which etiopathogenetic mechanisms are not well understood. There are different types of dementia, among which, Alzheimer’s disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD) are the more common. Currently approved pharmacological treatments for most forms of dementia seem to act only on symptoms without having profound disease-modifying effects. Thus, alternative strategies capable of preventing the progressive loss of specific neuronal populations are urgently required. In particular, the attention of researchers has been focused on phytochemical compounds that have shown antioxidative, anti-amyloidogenic, anti-inflammatory and anti-apoptotic properties and that could represent important resources in the discovery of drug candidates against dementia. In this review, we summarize the neuroprotective effects of the main phytochemicals belonging to the polyphenol, isothiocyanate, alkaloid and cannabinoid "CBD" families in the prevention and treatment of the most common kinds of dementia. We believe that natural phytochemicals may represent a promising sources of alternative medicine, at least in association with therapies approved to date for dementia.

CBD AND SEIZURES 
Cannabidiol "CBD" Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
Plant-derived cannabinoids (phytocannabinoids) are compounds with emerging therapeutic potential. Early studies suggested that cannabidiol (CBD) has anticonvulsant properties in animal models and reduced seizure frequency in human trials.